CBD (Cannabidiol) studies around the world part 2


In our previous article we talked about different studies concluded on CBD effects on anxiety, schizophrenia and arthritis. Let's look into Cannabidiol research on cancer and epilepsy.

Cannabidiol Cancer Research

Study on CBD effects on cancer concluded by researchers at California Pacific Medical Center in November 2007 found that CBD shows promise for controlling the spread of malignant breast tumors and even stalling metastasis (the process of cancerous cells spreading into different parts of the body) by “turning off” the activity of a gene responsible for tumor metastasis.

This research was followed by other numerous studies that have verified that cannabidiol exhibits some inhibitory effects on several types of cancer including breast cancer,colon cancer, certain types of brain tumors, leukemia and others. These results have been verified by dozens of scientific teams, although the exact inhibitory mechanisms are still unknown. Parallel to those studies, CBD has also been shown to inhibit benign tumor growth as well.

But there is more - CBD has been found to build up our body's ability to fight cancer! More specifically, CBD has been shown to induce programmed cell death in breast cancer cells by coordinating the cross-talk between two of our body’s defense mechanisms against cancer, apoptosis and autophagy. Apoptosis is the process of programmed cell death, while autophagy is the breakdown of individual cell components. Combined, these two processes weaken and destroy cancer cells.

Cannabidiol Epilepsy Research

Recent medical studies have shown that the use of Cannabidiol by patients with epilepsy might have a measurable, positive, and statistically significant effect in alleviating the symptoms and diminishing the seizures both in frequency and intensity. They are very important because they compare CBD’s effects on people suffering from epilepsy with healthy volunteers, giving a clear picture of how CBD affects the occurrence of seizures. However, the exact mechanism with which Cannabidiol inhibits epileptic seizures is still not fully understood.

While most studies on cannabidiol’s effects against epilepsy and seizures have been conducted on animals or even in vitro (in test tubes instead of in living organisms.), FDA-approved trials on human patients are already underway to examine whether Cannabidiol can be an effective treatment for epilepsy, especially among children. So far, the initial results have been most promising, but scientists are still conservative with regard to CBD’s potential to fully replace the most established anti-epileptic medications that are currently available to patients suffering from epilepsy or chronic seizures.

What's more, recent studies on children with epilepsy have shown a significant positive effect of CBD for use for treatment-resistant epilepsy, including a rare condition called Dravet’s syndrome, which causes epileptic seizures in children. These finds are critically important because treatment-resistant patients with epilepsy are often difficult cases where children respond weakly or not at all to conventional anti-epileptic medication.


Previous Post Next Post

  • John Yoda
Comments 0
Leave a comment
Your Name:*
Email Address:*
Message: *

Please note: comments must be approved before they are published.

* Required Fields